Pathology

  1. Development of a One-Step Qualitative RT-PCR Assay to Detect the SARS-CoV-2 Omicron (B.1.1.529) Variant in Respiratory Specimens

    1. Tung Phan
    2. Stephanie Boes
    3. Melissa McCullough
    4. Jamie Gribschaw
    5. Jane Marsh
    6. Lee H. Harrison
    7. Alan Wells

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas

    1. Paul A. Christensen
    2. Randall J. Olsen
    3. S. Wesley Long
    4. Richard Snehal
    5. James J. Davis
    6. Matthew Ojeda Saavedra
    7. Kristina Reppond
    8. Madison N. Shyer
    9. Jessica Cambric
    10. Ryan Gadd
    11. Rashi M. Thakur
    12. Akanksha Batajoo
    13. Regan Mangham
    14. Sindy Pena
    15. Trina Trinh
    16. Jacob C. Kinskey
    17. Guy Williams
    18. Robert Olson
    19. Jimmy Gollihar
    20. James M. Musser

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Utilization of a SARS-CoV-2 Variant Assay for the Rapid Differentiation of Omicron and Delta

    1. Nicholas Barasch
    2. Jameel Iqbal
    3. Marvin Coombs
    4. Sofia Kazi
    5. Jessica Wang-Rodriguez
    6. Mark Holodniy
    7. Michael Gelman

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2

    1. Jean-Sélim Driouich
    2. Maxime Cochin
    3. Franck Touret
    4. Paul-Rémi Petit
    5. Magali Gilles
    6. Grégory Moureau
    7. Karine Barthélémy
    8. Caroline Laprie
    9. Thanaporn Wattanakul
    10. Palang Chotsiri
    11. Richard M. Hoglund
    12. Joel Tarning
    13. Laurent Fraisse
    14. Peter Sjö
    15. Charles E. Mowbray
    16. Fanny Escudié
    17. Ivan Scandale
    18. Eric Chatelain
    19. Xavier de Lamballerie
    20. Caroline Solas
    21. Antoine Nougairède

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. SARS-CoV-2 Spike protein activates TMEM16F-mediated platelet pro-coagulant activity

    1. Ambra Cappelletto
    2. Harriet E. Allan
    3. Marilena Crescente
    4. Edoardo Schneider
    5. Rossana Bussani
    6. Hashim Ali
    7. Ilaria Secco
    8. Simone Vodret
    9. Roberto Simeone
    10. Luca Mascaretti
    11. Serena Zacchigna
    12. Timothy D. Warner
    13. Mauro Giacca

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Evaluation of SARS-CoV-2 antibody point of care devices in the laboratory and clinical setting

    1. Kirsty McCance
    2. Helen Wise
    3. Jennifer Simpson
    4. Becky Batchelor
    5. Harriet Hale
    6. Lindsay McDonald
    7. Azul Zorzoli
    8. Elizabeth Furrie
    9. Charu Chopra
    10. Frauke Muecksch
    11. Theodora Hatziioannou
    12. Paul D. Bieniasz
    13. Kate Templeton
    14. Sara Jenks

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Using patient biomarker time series to determine mortality risk in hospitalised COVID-19 patients: A comparative analysis across two New York hospitals

    1. Ben Lambert
    2. Isaac J. Stopard
    3. Amir Momeni-Boroujeni
    4. Rachelle Mendoza
    5. Alejandro Zuretti

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays

    1. Konrad H Stopsack
    2. Svitlana Tyekucheva
    3. Molin Wang
    4. Travis A Gerke
    5. J Bailey Vaselkiv
    6. Kathryn L Penney
    7. Philip W Kantoff
    8. Stephen P Finn
    9. Michelangelo Fiorentino
    10. Massimo Loda
    11. Tamara L Lotan
    12. Giovanni Parmigiani
    13. Lorelei A Mucci

    • Curated by eLife

      Evaluation Summary:

      Tissue microarrays (TMA) have become a mainstay in clinical and basic research, for both discovery and validation of biomarkers. This manuscript provides relevant methodologic considerations for cancer researchers investigating tissue-biomarkers using TMAs. A comprehensive investigation was conducted using a combination of analytic approaches using empirical data and simulated data to support key findings and conclusions. The authors approach the possible sampling variation in a thoughtful way, not only quantifying the issue systematically, but working towards a solution.

      (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. The reviewers remained anonymous to the authors.)

    Reviewed by eLife

    4 evaluationsAppears in 1 listLatest version Latest activity

  9. SARS-CoV-2 wildlife surveillance in Ontario and Québec

    1. JE Greenhorn
    2. JD Kotwa
    3. J Bowman
    4. L Bruce
    5. T Buchanan
    6. PA Buck
    7. CM Davy
    8. A Dibernardo
    9. L Flockhart
    10. M Gagnier
    11. A Hou
    12. CM Jardine
    13. S Lair
    14. LR Lindsay
    15. A Massé
    16. PK Muchaal
    17. LA Nituch
    18. A Sotto
    19. B Stevens
    20. L Yip
    21. S Mubareka

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Acute SARS-CoV-2 infection in pregnancy is associated with placental ACE-2 shedding

    1. Elizabeth S. Taglauer
    2. Elisha M. Wachman
    3. Lillian Juttukonda
    4. Timothy Klouda
    5. Jiwon Kim
    6. Qiong Wang
    7. Asuka Ishiyama
    8. David J. Hackam
    9. Ke Yuan
    10. Hongpeng Jia

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 10 of 20 Next